探索在严重喘中对乙酸性炎症的新观点
Claudio Candia1, Pasquale Ambrosino2, Silvestro E D'Anna2
1Department of Clinical Medicine & Surgery, Federico II University, Naples, 80131, Italy.
Biomarkers in medicine
|April 16, 2024
概括
严重的乙酸性喘患者有更多的CD62L低的炎症性乙酸 (iEos),与喘控制不良有关. 这些iEos随着梅波利祖马布治疗而减少,表明作为生物标志物的潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 过敏 过敏是一种过敏.
背景情况:
- 严重的乙酸性喘的特征是乙酸性的升高.
- 已经确定了一种特定的乙氨基酸亚型,即CD62L低的炎症性乙氨基酸 (iEos).
- 以前的研究指出,iEos和喘控制之间存在相关性.
研究的目的:
- 为了研究CD62L低的炎症性乙氨基酸在严重的乙氨基酸性喘中的作用.
- 评估抗IL-5治疗对iEos水平的影响.
- 探索埃索诺菲尔亚型作为喘管理中的生物标志物的潜力.
主要方法:
- 在患有严重埃索诺菲尔性喘的患者中分析埃索诺菲尔亚型.
- iEos比例与喘控制得分的相关性.
- 在治疗mepolizumab之前和之后评估iEos水平.
主要成果:
- 患有严重乙酸性喘的患者表现出较高比例的CD62L-低iEos.
- 在iEos水平和喘控制之间观察到显著的相关性.
- 梅波利祖马布治疗导致CD62L低的IEOS减少.
结论:
- 低CD62L的炎症性乙氨基酸可作为严重乙氨基酸性喘的有价值的生物标志物.
- 监测iEos可能有助于表征患者内型.
- 乙氨基亚型分析可能有助于预测对生物疗法的反应,如mepolizumab.
相关概念视频
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma: Pathogenesis and Management
391
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
391
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
284
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
284
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Drugs Used in Lower Respiratory Disorders: Overview
428
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
428


